RxConsultant.com

Save time, stay current, and earn CE. You can rely on The Rx Consultant to deliver practical easy-reading updates on drugs & therapy for front-line pharmacists and nurses.

CE for this article is no longer valid.
Non Subscriber: Buy This Issue

Posttraumatic Stress Disorder

Clicking the "View this Article" button will open the issue as a resizable PDF. To take the test for the issue, return to this Introduction page and click the "Take the Test" button. The Introduction page will remain open after you open this issue. You may need to re-size or close the issue in order to see the Introduction page.

Overview

Most traumatic events do not result in PTSD, however community practitioners may have seen an increasing number of patients with PTSD over the last several years due to the Iraq and Afghanistan wars, making understanding and awareness of this illness imperative. PTSD is often a chronic disorder linked with suicidal behaviors and high rates of coexisting conditions. While all classes of psychoactive medications have been studied, the largest body of evidence supports the use of selective serotonin reuptake inhibitors (SSRIs); sertraline and paroxetine are FDA approved for the treatment of PTSD. Non-SSRI antidepressants may be considered for patients who do not respond to SSRIs. Combinations of medications may be needed to adequately control symptoms. Anticonvulsants, antipsychotics, and adrenergic agents may be useful as add-on agents depending on which targeted symptoms are most prevalent in an individual.

This issue reviews all aspects of PTSD treatment including psychotherapy, targeting symptom clusters with medications, prevention/treatment of coexisting conditions, prevention of relapse, medication side effects and interactions, and considerations for an improved quality of life.

Details

Publication Date: 10/01/2010
Expiration Date: 10/01/2013
CE Credit: 1.5 (0.15 CEU)
Type of Activity: Knowledge-based

This program was developed by The Rx Consultant and published by Continuing Education Network, Inc. The Rx Consultant accepts no advertising or financial support from the pharmaceutical industry and is funded solely by the purchase of programs. The Rx Consultant is dedicated to providing unbiased, balanced information to health care practitioners.

Programs developed by The Rx Consultant are written by health care providers with expertise in the topic area, peer-reviewed, extensively edited, and fact-checked. This development process was created to insure that every program presents information that is current, accurate, relevant to "real world" health care providers, and written in an easy reading, "plain English" style.

Authors

Christine Johnston, Pharm.D., Mental Health Clinical Pharmacist, Department of Veterans Affairs Northern California Health Care System.

Disclosure Statement

Dr. Johnston reports no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.

Guest Editorial Advisor

Julie A. Dopheide, Pharm.D., BCPP

Target Audience

This accredited program is targeted to pharmacists and nurses.

Goals & Objectives

At the conclusion of this program, participants will be able to:

    1. Describe the clinical presentation of posttraumatic stress disorder, the diagnostic criteria, and the clinical course of disorder.
    2. Explain the limitations of the evidence in support of pharmacologic treatment strategies in order to best counsel patients.
    3. Identify drug and non-drug treatment options for the patient with PTSD. Individualize treatment based on guideline recommendations, individual patient presentation, predominant symptom clusters, presence of coexisting disorders, and potential for side effects.

Accreditation Statements

The Rx Consultant is a publication of Continuing Education Network, Inc. Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education as a provider of continuing pharmacy education.

Continuing Education Network is approved by the California Board of Registered Nursing, Provider Number CEP 13118. Programs approved by CA BRN are accepted by most State Boards of Nursing.

Exam & Credit Statement Procedures

Upon successful completion of this program and the post test (70%), 1.5 hours of continuing education credit will be awarded. To receive credit and your exam score, please complete the exam questions and program evaluation.

Editorial and Review Board

Editor and CE Administrator

Terry M. Baker, PharmD

Associate Editor and CE Coordinator

Tracy Farnen, PharmD

Associate Editors

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Coordinator
Kaiser Permanente
Oakland, CA

Associate Clinical Professor
School of Pharmacy
University of California San Francisco
San Francisco, CA

Ron Finley, RPh
Lecturer
Department of Clinical Pharmacy
University of California San Francisco
San Francisco, CA

Associate Member of the UCSF Memory and Aging Center
Alzheimer's Research Center

Consultant Pharmacist to the Institute on Aging-On Lok Senior Health
Institute on Aging Alzheimer's Day Care Center

Angie S. Graham, PharmD
Drug Information Coordinator
Stanford Hospital and Clinics
Stanford University Medical Center
Stanford, CA

Julio R. Lopez, PharmD, FCSHP
Chief of Pharmacy Service
VA Northern California Health Care System

Adjunct Clinical Professor
College of Pharmacy
Touro University
Vallejo, CA

Assistant Clinical Professor
School of Pharmacy
University of California, San Francisco
San Francisco, CA

Adjunct Professor
Thomas J. Long School of Pharmacy
University of the Pacific
Stockton, CA

Visiting Associate Professor and Lecturer
Nursing School
Samuel Merritt University
Oakland, CA

Pamela Mausner, MD

Joshua J. Neumiller, PharmD, CDE, CGP, FASCP
Assistant Professor
Department of Pharmacotherapy
College of Pharmacy
Washington State University
And
Elder Services of Spokane
Spokane, WA

Candy Tsourounis, PharmD
Professor of Clinical Pharmacy
Medication Outcomes Center
Department of Clinical Pharmacy
School of Pharmacy
University of California, San Francisco
San Francisco, CA

Senior Editorial Advisor

Gerard Hatheway, PharmD, PhD

Editorial Advisors

Jocelyn Chan, PharmD
Belinda M. Danielson, RPh
Christopher M. DeSoto, PharmD
Cynthia Chan Huang, PharmD, MBA
Fred Plageman, PharmD


Editorial Advisor and Clinical Practice Consultant for Nurse Practitioners

Emily K. Meuleman, RN, C, MS

About the Rx Consultant

The Rx Consultant is a monthly publication dedicated to providing health care professionals with the information they need to educate patients about drugs and manage drug therapy. The reader is responsible for confirming the information presented here and interpreting it in relation to each patient's specific situation before utilizing the information.

Contact Us

Exam Processing Inquiries

The Rx Consultant
mail@rxconsultant.com
1-800-798-3353

Educational Content Inquiries

The Rx Consultant
editor@rxconsultant.com
1-800-798-3353

CE for this article is no longer valid.
Non Subscriber: Buy This Issue